+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

United States Vaccines Market Size, Top 47 Vaccines Brand In-depth Analysis, Insights, and Forecasts to 2033 - Product Thumbnail Image

United States Vaccines Market Size, Top 47 Vaccines Brand In-depth Analysis, Insights, and Forecasts to 2033

  • Report
  • May 2025
  • 230 Pages
  • United States
From
Bioterrorism Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Bioterrorism Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • September 2024
  • 84 Pages
  • Global
From
Biodefense Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Biodefense Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 90 Pages
  • Global
From
U.S. Vaccines, Skin Replacement Products and Biologicals Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 - Product Thumbnail Image

U.S. Vaccines, Skin Replacement Products and Biologicals Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030

  • Report
  • September 2024
  • 103 Pages
  • United States
From
Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032) - Product Thumbnail Image

Influenza Vaccines Market, Persons Vaccinated, By Segment - Vaccine Type, Indication, Technology, Route of Administration, End-user, Geography, Company Analysis - Global Forecast (2025 - 2032)

  • Report
  • January 2025
  • 388 Pages
  • Global
From
Global Markets for Vaccine Technologies - Product Thumbnail Image

Global Markets for Vaccine Technologies

  • Report
  • January 2024
  • 213 Pages
  • Global
From
Shigellosis - Pipeline Insight, 2025 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034 - Product Thumbnail Image

Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2024-2034

  • Report
  • October 2023
  • 428 Pages
  • Global
From
Pneumococcal Vaccines - Global Strategic Business Report - Product Thumbnail Image

Pneumococcal Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 285 Pages
  • Global
From
Cholera Vaccines - Global Strategic Business Report - Product Thumbnail Image

Cholera Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 367 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Conjugate Vaccines - Global Strategic Business Report - Product Thumbnail Image

Conjugate Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 271 Pages
  • Global
From
Multivalent Vaccines - Global Strategic Business Report - Product Thumbnail Image

Multivalent Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 278 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 485 Pages
  • Global
From
Toxoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Toxoid Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 282 Pages
  • Global
From
Typhoid Fever Vaccines - Global Strategic Business Report - Product Thumbnail Image

Typhoid Fever Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 372 Pages
  • Global
From
Respiratory Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Virus Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 474 Pages
  • Global
From
Digital Vaccines - Global Strategic Business Report - Product Thumbnail Image

Digital Vaccines - Global Strategic Business Report

  • Report
  • August 2025
  • 274 Pages
  • Global
From
Loading Indicator